| Key features | - Six published research signals averaged into stock ratings
- Free access to ratings on the 200 largest US stocks
- Company financial analysis and sector comparisons
- Stock screening on valuation, profitability, growth and momentum
- Rules-based paper portfolio tracking with simulated trading
- Custom paper portfolios with historical backtesting
- Analyst estimates and DCF valuation tools
- CSV export for custom analysis
- Rating changes tracked weekly by signal
| - 30-second stock analysis with DNA score from 0-100
- Analysis across 2,000+ signals spanning fundamentals, valuation, technicals, momentum, sentiment, and risk
- Ten composite category scores including Business Quality, Growth Outlook, Financial Strength, Valuation, Institutional, Trend & Structure, Momentum, Relative Strength, Risk, and News Sentiment
- Plain-English breakdowns of quantitative analysis
- Side-by-side stock comparison with dual DNA radars
- Stock screener with pre-built theme baskets including Penny Stocks, Growth Stocks, Value Stocks, Dividend Income, Quality Blue-Chips, Momentum Breakouts, Oversold Bounces, and High Risk/High Reward
- Watchlist that tracks DNA score changes for each stock
- Daily score updates recalculated each evening after market close
- Free financial calculators including Buffett Score, Intrinsic Value, DCF Calculator, PEG Calculator, Compound Interest, and Retirement Projector
- Access to 5,200+ analyzed US stocks
|
|---|
| What makes it different | - Connects stock screening with company research and paper portfolio tracking in one workspace
- Ratings based on six published academic research signals, not proprietary black boxes
- Free access to research on largest 200 stocks, no credit card required
- Educational research and ranking signals, explicitly not investment advice
- Affordable paid plan at $2 first month then $29/month with backtesting and full universe access
| - Converts 2,000+ data points into one instantly understandable 0-100 DNA score instead of hours of spreadsheet research
- Fixed, published formula methodology rather than subjective analyst opinions
- Scores recalculated daily with real-time quote updates rather than static quarterly snapshots
- Presents scores as objective data-driven labels rather than buy/sell recommendations
- Analyzes institutional ownership, sentiment, and technicals alongside fundamentals in one composite view
|
|---|
Tessera Alpha
StockDNA